- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
172
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
172 companies
Zhejiang CONBA PharmaceuticalLtd
Market Cap: CN¥11.5b
Engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China.
600572
CN¥4.55
7D
0.9%
1Y
3.2%
Tong Ren Tang Technologies
Market Cap: HK$5.6b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.41
7D
-2.0%
1Y
-8.9%
JBM (Healthcare)
Market Cap: HK$2.3b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.78
7D
-0.4%
1Y
58.0%
Hyphens Pharma International
Market Cap: S$105.0m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.34
7D
-1.4%
1Y
19.3%
Rhone Ma Holdings Berhad
Market Cap: RM 151.9m
An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.
RHONEMA
RM 0.69
7D
-1.4%
1Y
3.8%
Medical Developments International
Market Cap: AU$58.0m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.52
7D
-8.0%
1Y
27.2%
Pharming Group
Market Cap: €1.0b
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€1.52
7D
-3.4%
1Y
74.8%
Kotra Industries Berhad
Market Cap: RM 618.5m
An investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia.
KOTRA
RM 4.17
7D
0.2%
1Y
-1.9%
Faes Farma
Market Cap: €1.5b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.
FAE
€4.95
7D
-4.6%
1Y
44.1%
Vita Life Sciences
Market Cap: AU$136.6m
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.
VLS
AU$2.50
7D
-10.4%
1Y
26.9%
Lee's Pharmaceutical Holdings
Market Cap: HK$924.5m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$1.57
7D
-5.4%
1Y
27.6%
Pak Fah Yeow International
Market Cap: HK$744.8m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.39
7D
-0.4%
1Y
-4.0%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥7.8b
Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
002437
CN¥3.51
7D
7.3%
1Y
39.3%
Oramed Pharmaceuticals
Market Cap: US$146.5m
Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
ORMP
US$3.52
7D
3.8%
1Y
53.0%
SSY Group
Market Cap: HK$8.6b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.98
7D
-3.2%
1Y
-5.4%
Aroa Biosurgery
Market Cap: AU$238.1m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.69
7D
-8.6%
1Y
-8.6%
Adagene
Market Cap: US$92.4m
A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.
ADAG
US$1.87
7D
10.0%
1Y
5.5%
MediciNova
Market Cap: US$78.6m
A biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
MNOV
US$1.68
7D
15.9%
1Y
-8.7%
Tianjin Chase Sun PharmaceuticalLtd
Market Cap: CN¥10.9b
Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.
300026
CN¥3.62
7D
-2.4%
1Y
1.1%
Sopharma AD
Market Cap: €1.0b
Produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.
SFA
€1.96
7D
1.3%
1Y
100.1%
Molecular Partners
Market Cap: CHF 119.7m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 3.13
7D
-6.2%
1Y
-32.2%
OnKure Therapeutics
Market Cap: US$40.6m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers.
OKUR
US$2.98
7D
-5.3%
1Y
-49.6%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.10
7D
-0.5%
1Y
45.8%
Pharmesis International
Market Cap: S$11.1m
An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.
BFK
S$0.35
7D
62.8%
1Y
-38.6%
IDL Diagnostics
Market Cap: SEK 81.3m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.35
7D
2.3%
1Y
-29.6%
Covalon Technologies
Market Cap: CA$48.0m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.
COV
CA$1.66
7D
-5.1%
1Y
-45.0%
Acrivon Therapeutics
Market Cap: US$62.5m
A clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.
ACRV
US$1.96
7D
15.3%
1Y
-65.3%
Apex Healthcare Berhad
Market Cap: RM 1.9b
An investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally.
AHEALTH
RM 2.61
7D
0%
1Y
8.8%
Auxly Cannabis Group
Market Cap: CA$191.4m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.14
7D
-3.4%
1Y
180.0%
Guizhou Xinbang Pharmaceutical
Market Cap: CN¥6.3b
Manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally.
002390
CN¥3.31
7D
-2.1%
1Y
-20.6%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.8b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.17
7D
-2.5%
1Y
0%
ProKidney
Market Cap: US$688.9m
A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.
PROK
US$2.14
7D
-6.6%
1Y
19.6%
High Tide
Market Cap: CA$311.9m
Engages in the cannabis retail business in Canada.
HITI
CA$3.55
7D
-4.3%
1Y
-17.8%
Arterra Bioscience
Market Cap: €22.5m
A research-based biotech company, engages in the research and development of various ingredients and natural solutions.
ARBS
€3.28
7D
7.9%
1Y
66.5%
Cellectis
Market Cap: €252.8m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
ALCLS
€3.47
7D
-2.1%
1Y
130.1%
Botanix Pharmaceuticals
Market Cap: AU$256.1m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.13
7D
-3.7%
1Y
-71.7%